Quinolone BCL6 Bifunctional Degraders

JP2025525325A5Pending Publication Date: 2026-06-08TREELINE BIOSCIENCES INC

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
TREELINE BIOSCIENCES INC
Filing Date
2023-06-05
Publication Date
2026-06-08

Smart Images

  • Figure 2023244918000001
    Figure 2023244918000001
  • Figure 2023244918000002
    Figure 2023244918000002
  • Figure 2023244918000003
    Figure 2023244918000003
Patent Text Reader

Abstract

The present disclosure provides compounds of Formula (I) (e.g., Formula (I-aa) (e.g., Formula (I-aa-1), (I-aa-2), (I-aa-3), or (I-aa-4)), Formula (Ia) (e.g., Formula (Ia-1), (Ia-2), (Ia-3), or (Ia-4)), Formula (I-bb) (e.g., Formula (I-bb-1) or (I-bb-2)), or Formula (Ib) (e.g., Formula (Ib-1) or (Ib-2))), or Formula (II), or a pharmaceutically acceptable salt thereof, which induce degradation of BCL6 protein. These compounds are useful, for example, for treating cancer in a subject (e.g., a human). The present disclosure also provides compositions containing the compounds, as well as methods of using and preparing them.
Need to check novelty before this filing date? Find Prior Art